UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:February 05,
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more aTyr Pharma Charts.
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more aTyr Pharma Charts.

Atyr Pharma Inc News

aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
Friday 3 May 2024 (2 days ago) • GlobeNewswire Inc.
aTyr Pharma to Participate in April Investor Conferences
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
Friday 15 March 2024 (2 months ago) • GlobeNewswire Inc.
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
Thursday 22 February 2024 (2 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
Tuesday 30 January 2024 (3 months ago) • GlobeNewswire Inc.
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
Friday 19 January 2024 (4 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 10 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 10 January 2024 (4 months ago) • Edgar (US Regulatory)
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Wednesday 3 January 2024 (4 months ago) • Edgar (US Regulatory)

More Atyr Pharma Inc News Articles